MedTrace Logo

Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial

NCT06922578 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-04-10

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to evaluate the clinical and radiographic success of pulpotomy using Neoputty MTA vital primary molars diagnosed with symptomatic irreversible pulpitis.

The main question it aims to answer is:

Will Neoputty MTA pulpotomy have higher clinical and radiographic success in comparison to Endoflas pulpectomy in primary molars with irreversible pulpitis?

Conditions

  • Pulpitis - Irreversible

Interventions

PROCEDURE

NeoPUTTY MTA pulpotomy

Neoputty MTA pulpotomy performed in vital primary molars with symptomatic irreversible pulpitis

PROCEDURE

Endoflas pulpectomy

Endoflas pulpectomy in vital primary molars with symptomatic irreversible pulpitis

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • DR · assistant lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-05-01
Completion
2026-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06922578 on ClinicalTrials.gov